Gene expression analyses of the liver in rats treated with oxfendazole

Archives of Toxicology

Volumn 81, Issue 9, 2007, Pages 647-654

  Dewa, Yasuaki ^a   Nishimura, Jihei ^a,b   Muguruma, Masako ^a   Matsumoto, Sayaka ^a   Takahashi, Miwa ^c   Jin, Meilan ^a,d   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Cytochrome P450 induction; Oxfendazole; Oxidative stress; Rat

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; DRUG METABOLIZING ENZYME; GLUTATHIONE TRANSFERASE; OXFENDAZOLE; QUINONE 1; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; LIPID PEROXIDATION; LIVER; LIVER CARCINOGENESIS; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; XENOBIOTIC METABOLISM;

ALKALINE PHOSPHATASE; ANIMALS; ANTHELMINTICS; ASPARTATE AMINOTRANSFERASES; BENZIMIDAZOLES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UP-REGULATION;

RATTUS;

EID: 34547752505     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-007-0190-9     Document Type: Article

References (40)

1. Aix L, Rey-Grobellet X, Larrieu G, Lesca P, Galtier P (1994) Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochem Biophys Res Commun 202:1483-1489
2. Aoki Y, Sato H, Nishimura N, Takahashi S, Itoh K, Yamamoto M (2001) Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol 173:154-160
3. Baliharova V, Skalova L, Maas RF, De Vrieze G, Bull S, Fink-Gremmels J (2003) The effects of benzimidazole anthelmintics on P4501A in rat hepatocytes and HepG2 cells. Res Vet Sci 75:61-69
4. Brigelius-Flohe R (1999) Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 27:951-965
5. Chu FF, Doroshow JH, Esworthy RS (1993) Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI. J Biol Chem 268:2571-2576
6. Daujat M, Peryt B, Lesca P, Fourtanier G, Domergue J, Maurel P (1992) Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochem Biophys Res Commun 188:820-825
7. Delatour P, Parish R (1986) Benzimidazole anthelmintics and related compounds: toxicity and evaluation of residues. In: Rico AG (ed) Drug residues in animals. Academic, New York, pp 175-204
8. Diaz D, Fabre I, Daujat M, Saint Aubert B, Bories P, Michel H, Maurel P (1990) Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 99:737-747
9. Diwan BA, Rice JM, Nims RW, Lubet RA, Hu H, Ward JM (1988) P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats. Cancer Res 48:2492-2497
10. Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, O'Connor T, Harada T, Yamamoto M (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci 59:169-177
11. Gleizes C, Eeckhoutte C, Pineau T, Alvinerie M, Galtier P (1991) Inducing effect of oxfendazole on cytochrome P450IA2 in rabbit liver. Consequences on cytochrome P450 dependent monooxygenases. Biochem Pharmacol 41:1813-1820
12. Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600
13. Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 31:273-300
14. Hayes JD, Judah DJ, Neal GE (1993) Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res 53:3887-3894
15. Ito N, Hasegawa R, Imaida K, Hirose M, Shirai T (1996) Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp Toxicol Pathol 48:113-119
16. Jacobs DEJ, Taylor MA (2001) Drugs used in the treatment and control of parasitic infections. In: Bishop J (ed) The Veterinary Formulary, 5th edn. Pharmaceutical Press, London, pp 219-245
17. Judah DJ, Hayes JD, Yang JC, Lian LY, Roberts GC, Farmer PB, Lamb JH, Neal GE (1993) A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant. Biochem J 292:13-18
18. Kikuchi H, Hossain A, Yoshida H, Kobayashi S (1998) Induction of cytochrome P-450 1A1 by omeprazole in human HepG2 cells is protein tyrosine kinase-dependent and is not inhibited by alpha-naphthoflavone. Arch Biochem Biophys 358:351-358
19. Kitahara A, Satoh K, Nishimura K, Ishikawa T, Ruike K, Sato K, Tsuda H, Ito N (1984) Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis. Cancer Res 44:2698-703
20. Klaunig JE, Ruch RJ (1990) Role of inhibition of intercellular communication in carcinogenesis. Lab Invest 62:135-146
21. Knerr S, Schaefer J, Both S, Mally A, Dekant W, Schrenk D (2006) 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cytochrome P450s alter the formation of reactive oxygen species in liver cells. Mol Nutr Food Res 50:378-384
22. Kwak MK, Itoh K, Yamamoto M, Kensler TW (2002) Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 22:2883-2892
23. Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW (2003) Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 278:8135-8145
24. Lemaire G, Delescluse C, Pralavorio M, Ledirac N, Lesca P, Rahmani R (2004) The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes. Life Sci 74:2265-2278
25. Locatelli C, Pedrosa RC, De Bem AF, Creczynski-Pasa TB, Cordova CA, Wilhelm-Filho D (2004) A comparative study of albendazole and mebendazole-induced, time-dependent oxidative stress. Redox Rep 9:89-95
26. McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, Wolf CR, Cavin C, Hayes JD (2001) The Cap'n'collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61:3299-3307
27. Mitsumori K, Onodera H, Shoda T, Uneyama C, Imazawa T, Takegawa K, Yasuhara K, Watanabe T, Takahashi M (1997) Liver tumour-promoting effects of oxfendazole in rats. Food Chem Toxicol 35:799-806
28. Moto M, Okamura M, Muto T, Kashida Y, Machida N, Mistumori K (2005) Molecular pathological analysis on the mechanism of liver carcinogenesis in dicyclanil-treated mice. Toxicology 207:419-436
29. Noda S, Harada N, Hida A, Fujii-Kuriyama Y, Motohashi H, Yamamoto M (2003) Gene expression of detoxifying enzymes in AhR and Nrf2 compound null mutant mouse. Biochem Biophys Res Commun 303:105-111
30. Ohkawa H, Ohnishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
31. Park JY, Shigenaga MK, Ames BN (1996) Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. Proc Natl Acad Sci USA 93:2322-2327
32. Riley RJ, Workman P (1992) DT-diaphorase and cancer chemotherapy. Biochem Pharmacol 43:1657-1669
33. Schlezinger JJ, Struntz WD, Goldstone JV, Stegeman JJ (2006) Uncoupling of cytochrome P450 1A and stimulation of reactive oxygen species production by co-planar polychlorinated biphenyl congeners. Aquat Toxicol 77:422-432
34. Shoda T, Onodera H, Takeda M, Uneyama C, Imazawa T, Takegawa K, Yasuhara K, Watanabe T, Hirose M, Mitsumori K (1999) Liver tumor promoting effects of fenbendazole in rats. Toxicol Pathol 27:553-562
35. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y (1995) Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82-83:173-179
36. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62:5196-5203
37. Umemura T, Kuroiwa Y, Kitamura Y, Ishii Y, Kanki K, Kodama Y, Itoh K, Yamamoto M, Nishikawa A, Hirose M (2006) A crucial role of Nrf2 in in vivo defense against oxidative damage by an environmental pollutant, pentachlorophenol. Toxicol Sci 90:111-119
38. Velik J, Baliharova V, Fink-Gremmels J, Bull S, Lamka J, Skalova L (2004) Benzimidazole drugs and modulation of biotransformation enzymes. Res Vet Sci 76:95-108
39. WHO (1991) Residues of some veterinary drugs in animals and foods. In: Monographs prepared by the 38th meeting of the Joint FAO/WHO Expert Committee on Food Additives, vol 41, FAO food nutr pap, pp 1-136
40. WHO (1999) Evaluation of certain veterinary drug residues in food. Fiftieth report of the joint FAO/WHO Expert Committee on Food Additives, vol 888, world health organ tech rep ser, pp 1-95